
Keftra 125mg Injection
Marketer
Ipca Laboratories Ltd
Salt Composition
Ceftriaxone (125mg)
Overview Keftra 125mg Injection
Cefazolin 125mg injection, a cephalosporin antibiotic, combats bacterial infections throughout the body. Its applications span diverse sites including the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it can prevent surgical infections. Administered intravenously (IV drip) or intramuscularly by a healthcare professional, the dosage is determined individually. Regularly spaced doses, as directed, are crucial; completing the entire course is vital to prevent relapse. Premature cessation may result in infection recurrence or exacerbation. Common side effects encompass diarrhea, rashes, altered liver function test results, and variations in blood cell counts (e.g., eosinophilia, leukopenia, thrombocytopenia). Injection site erythema or pain may occur temporarily. While generally mild, persistent or bothersome effects require medical attention. Prior to use, disclose any antibiotic allergies, kidney or liver conditions, and all other medications being taken, as interactions may occur.
Primary Ingredients of Keftra 125mg Injection
No text provided to rephrase.
Uses of Keftra 125mg Injection
Managing bacterial illnesses
Major Benefits of Keftra 125mg Injection:
This medication will be administered by your physician or their qualified nursing staff; self-medication is strictly prohibited.
Common Side effects of Keftra 125mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Keftra 125mg Injection:
Administering this medication will be done by your healthcare provider; please do not attempt self-medication.
How Keftra 125mg Injection works:
Cefazolin 125mg injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Keftra 125mg Injection and alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Keftra 125mg Injection is considered safe; research indicates minimal or nonexistent fetal risk.
Breast feedingCAUTION
Administering Keftra 125mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Keftra 125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneySAFE IF PRESCRIBED
Cefazolin 125mg injection poses no safety concerns for patients with renal impairment; dose modification is unnecessary. Nevertheless, disclosure of pre-existing kidney disease to your physician is advised.
LiverCAUTION
Cefazolin 125mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Cefazolin 125mg Injection is not advised for those with mild or moderate liver dysfunction.
What if you forget to take Keftra 125mg Injection :
Omit a Keftra 125mg Injection dose? Seek your physician's advice.
Facts to Know About Keftra 125mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
